top of page

Medical Device Law Attorney

From bandages to diagnostic software, medical devices cover a vast field, governed since 2021-2022 by two directly applicable European regulations: Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). Our firm assists manufacturers, authorized representatives, importers, distributors, and healthcare software publishers in ensuring compliance and protecting their products.

Areas of intervention

Recherche & Développement

  • Contrats de développement, co-développement, licences, propriété intellectuelle

  • Investigations cliniques (MDR) et études des performances (IVDR) : contrats, autorisations, ANSM/CPP

  • Évaluation clinique et démonstration des performances

Accès au marché et remboursement

  • LPPR, transitional care and PECAN, remote monitoring

  • Hospital purchases, public procurement

  • Strategy for managing digital medical devices

Promotion & Relations with Healthcare Professionals

  • Advertising of medical devices/in vitro diagnostic medical devices, performance claims

  • Article 7 of the MDR

  • Conferences, demonstrations, loans and deposits

Digital Health

  • Clinical data from research and real-life data

  • GDPR compliance applied to healthcare, patient consent, HDS hosting

  • Digital projects: disease awareness, Patient Support Programs, AI tools

  • Connected devices

Marquage CE et certification

  • Relations et contrats avec les organismes notifiés

  • Documentation technique, UDI, étiquetage

  • Périodes transitoires MDR/IVDR, maintien et litiges de certificats​

Economic operators & Supply chain

  • Obligations of the manufacturer, agent, importer, distributor

  • PRRC / PCVRR

  • OEM contracts, quality agreements, relabeling and repackaging

  • Import/export

Compliance / Benefits Framework

  • DMOS/LEA (anti-gifts) and transparency of conflicts of interest

  • Ethics and compliance: relations with HCPs, HCOs and patient associations (POs); coordination with Sapin II

  • Creation and updating of internal documents (Guidebook, SOPs, guidelines); training, internal audits and investigations

Matériovigilance et Surveillance

  • Signalements d’incidents, FSCA et rappels

  • PMS, PMCF, PSUR

  • Gestion de crise

  • Décisions de police sanitaire ANSM, contrôles DGCCRF · Litiges avec les organismes notifiés​

Medical devices and in vitro diagnostic medical devices

Products whose regulatory compliance ensures a competitive advantage and which have become indispensable in the medical world.

The firm supports operators in the medical device and in vitro diagnostic medical device sectors — manufacturers, importers, distributors or clinical investigation partners.

Precise knowledge of the applicable regulations, derived from the public health code and European Union law, makes it possible to carry out the necessary compliance measures and to prevent the problems that arise from them: qualification of products as DM/DMDIV, regulatory classification, assistance with CE marking or the drafting of clinical investigation files, advertising, distribution, materiovigilance.

It also allows the firm to support operators in the context of ANSM health control and policing measures, as well as DGCCRF investigations.

Unlike medicines, medical devices are not subject to prior administrative authorization: they are placed on the market under the responsibility of the manufacturer, via CE marking, after a conformity assessment procedure which depends on the risk class of the product (I, IIa, IIb, III) and involves, except for the least risky devices, a notified body.

The Medical Devices Regulation 2017/745 (MDR) has considerably strengthened the requirements: clinical evaluation, post-market surveillance, unique identification (UDI), obligations specific to each economic operator.

Software — including applications incorporating artificial intelligence — can be medical devices in their own right, with qualification issues often being delicate.

bottom of page